gemcitabine has been researched along with Hypoalbuminemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Iede, K; Ikenaga, M; Koh, M; Matsuyama, J; Nakashima, S; Ohta, K; Tanida, T; Tominaga, S; Tsuda, Y; Ueda, M; Yamada, T | 1 |
| Abrams, T; Aguirre, AJ; Bakir, B; Blaszkowsky, L; Brais, L; Chiarella, AM; Cleary, JM; Das, K; Enzinger, P; Germon, V; Giannakis, M; Giantonio, BJ; Goessling, W; Goyal, L; Horick, N; Meyerhardt, JA; Needle, M; Perez, K; Pitarresi, JR; Raghavan, S; Rubinson, D; Rustgi, AK; Stonely, D; Weekes, C; Wolpin, BM; Yurgelun, MB | 1 |
| Bajwa, R; Daily, K; Starr, J | 1 |
1 trial(s) available for gemcitabine and Hypoalbuminemia
| Article | Year |
|---|---|
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Combined Chemotherapy Protocols; Edema; Female; Gemcitabine; Humans; Hypoalbuminemia; Male; Paclitaxel; Pancreatic Neoplasms | 2023 |
2 other study(ies) available for gemcitabine and Hypoalbuminemia
| Article | Year |
|---|---|
Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Hypoalbuminemia; Paclitaxel; Pancreatic Neoplasms; Retrospective Studies; Sarcopenia | 2022 |
Gemcitabine-induced chronic systemic capillary leak syndrome.
Topics: Antimetabolites, Antineoplastic; Capillary Leak Syndrome; Deoxycytidine; Edema; Female; Gemcitabine; Humans; Hypoalbuminemia; Hypotension; Middle Aged; Pancreatic Neoplasms | 2017 |